0001415889-21-002243.txt : 20210504
0001415889-21-002243.hdr.sgml : 20210504
20210504163928
ACCESSION NUMBER: 0001415889-21-002243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210501
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham Ann Michelle
CENTRAL INDEX KEY: 0001764572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 21889199
MAIL ADDRESS:
STREET 1: 255 N CALDWELL CIRCLE
CITY: DOWNINGTOWN
STATE: PA
ZIP: 19335
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-05042021_010553.xml
X0306
4
2021-05-01
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001764572
Cunningham Ann Michelle
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
CHIEF COMMERCIAL OFFICER
Stock Option (Right to Buy)
2.53
2021-05-01
4
A
0
300000
0
A
2031-05-01
Common Stock
300000
300000
D
25% of the stock options vest on the one-year anniversary of the grant date, with the remaining 75% vesting ratably on a monthly basis over the 36 months thereafter. Stock options were granted in connection with the Reporting Person's appointment to the Issuer's Board of Directors and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.
/s/ Jerrold D. Dotson, Attorney-in-Fact
2021-05-04